Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Ramon Parsons
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Genes & Molecular Sequences
Anatomy
Living Beings
Disorders
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
10
Hibshoosh, Hanina
9
Wang, SI
7
Memeo, Lorenzo
7
Li, Jing
7
Podsypanina, Katrina
6
Puc, Janusz
6
Saal, Lao
6
Koujak, Susan
6
Su, Tao
5
Simpson, Laura
5
Maurer, Matthew
5
Gruvberger-Saal, Sofia
5
Bose, S
4
Borg, Ake
4
Liaw, D
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Ramon Parsons (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Fine Barry; Hodakoski Cindy; Koujak Susan; Su Tao; Saal Lao H; Maurer Matthew; Hopkins Benjamin; Keniry Megan; Sulis Maria Luisa; Mense Sarah; Hibshoosh Hanina; Parsons Ramon
Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a.
Science (New York, N.Y.) 2009;325(5945):1261-5.
-
2009: Maurer Matthew; Su Tao; Saal Lao H; Koujak Susan; Hopkins Benjamin D; Barkley Christina R; Wu Jiaping; Nandula Subhadra; Dutta Bhaskar; Xie Yuli; Chin Y Rebecca; Kim Da-In; Ferris Jennifer S; Gruvberger-Saal Sofia K; Laakso Mervi; Wang Xiaomei; Memeo Lorenzo; Rojtman Albert; Matos Tulio; Yu Jennifer S; Cordon-Cardo Carlos; Isola Jorma; Terry Mary Beth; Toker Alex; Mills Gordon B; Zhao Jean J; Murty Vundavalli V V S; Hibshoosh Hanina; Parsons Ramon
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
Cancer research 2009;69(15):6299-306.
-
2009: Horst Basil; Gruvberger-Saal Sofia K; Hopkins Benjamin D; Bordone Lindsey; Yang Ying; Chernoff Karen A; Uzoma Ijeoma; Schwipper Volker; Liebau Jutta; Nowak Norma J; Brunner Georg; Owens David; Rimm David L; Parsons Ramon; Celebi Julide Tok
Gab2-mediated signaling promotes melanoma metastasis.
The American journal of pathology 2009;174(4):1524-33.
-
2009: Szabolcs Matthias; Keniry Megan; Simpson Laura; Reid Latarsha J; Koujak Susan; Schiff Sarah C; Davidian Giselle; Licata Scott; Gruvberger-Saal Sofia; Murty Vundavalli V V S; Nandula Subhadra; Efstratiadis Argiris; Kushner Jake A; White Morris F; Parsons Ramon
Irs2 inactivation suppresses tumor progression in Pten+/- mice.
The American journal of pathology 2009;174(1):276-86.
-
2008: Keniry M; Parsons R
The role of PTEN signaling perturbations in cancer and in targeted therapy.
Oncogene 2008;27(41):5477-85.
-
2008: Yu J S; Koujak S; Nagase S; Li C-M; Su T; Wang X; Keniry M; Memeo L; Rojtman A; Mansukhani M; Hibshoosh H; Tycko B; Parsons R
PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer.
Oncogene 2008;27(34):4657-65.
-
2008: Xia Wei; Nagase Satoru; Montia Amy Gerstein; Kalachikov Sergey M; Keniry Megan; Su Tao; Memeo Lorenzo; Hibshoosh Hanina; Parsons Ramon
BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.
Cancer research 2008;68(6):1667-74.
-
2008: Saal Lao H; Gruvberger-Saal Sofia K; Persson Camilla; Lövgren Kristina; Jumppanen Mervi; Staaf Johan; Jönsson Göran; Pires Maira M; Maurer Matthew; Holm Karolina; Koujak Susan; Subramaniyam Shivakumar; Vallon-Christersson Johan; Olsson Håkan; Su Tao; Memeo Lorenzo; Ludwig Thomas; Ethier Stephen P; Krogh Morten; Szabolcs Matthias; Murty Vundavalli V V S; Isola Jorma; Hibshoosh Hanina; Parsons Ramon; Borg Ake
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair.
Nature genetics 2008;40(1):102-7.
-
2007: Palomero Teresa; Sulis Maria Luisa; Cortina Maria; Real Pedro J; Barnes Kelly; Ciofani Maria; Caparros Esther; Buteau Jean; Brown Kristy; Perkins Sherrie L; Bhagat Govind; Agarwal Archana M; Basso Giuseppe; Castillo Mireia; Nagase Satoru; Cordon-Cardo Carlos; Parsons Ramon; Zúñiga-Pflücker Juan Carlos; Dominguez Maria; Ferrando Adolfo A
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia.
Nature medicine 2007;13(10):1203-10.
-
2007: Persson Oscar; Krogh Morten; Saal Lao H; Englund Elisabet; Liu Jian; Parsons Ramon; Mandahl Nils; Borg Ake; Widegren Bengt; Salford Leif G
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
Journal of neuro-oncology 2007;85(1):11-24.
-
2007: Saal Lao H; Johansson Peter; Holm Karolina; Gruvberger-Saal Sofia K; She Qing-Bai; Maurer Matthew; Koujak Susan; Ferrando Adolfo A; Malmström Per; Memeo Lorenzo; Isola Jorma; Bendahl Pär-Ola; Rosen Neal; Hibshoosh Hanina; Ringnér Markus; Borg Ake; Parsons Ramon
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(18):7564-9.
-
2006: Puc Janusz; Placha Grzegorz; Wocial Bozenna; Podsypanina Katrina; Parsons Ramon; Gaciong Zbigniew
Analysis of PTEN mutation in non-familial pheochromocytoma.
Annals of the New York Academy of Sciences 2006;1073():317-31.
-
2006: Gruvberger-Saal Sofia K; Parsons Ramon
Is the small heat shock protein alphaB-crystallin an oncogene?
The Journal of clinical investigation 2006;116(1):30-2.
-
2005: Parsons Ramon
Phosphatidylinositol 3-kinase inhibitors are a triple threat to ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(22):7965-6.
-
2005: Puc Janusz; Parsons Ramon
PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells.
Cell cycle (Georgetown, Tex.) 2005;4(7):927-9.
-
2005: Saal Lao H; Holm Karolina; Maurer Matthew; Memeo Lorenzo; Su Tao; Wang Xiaomei; Yu Jennifer S; Malmström Per-Olof; Mansukhani Mahesh; Enoksson Jens; Hibshoosh Hanina; Borg Ake; Parsons Ramon
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma.
Cancer research 2005;65(7):2554-9.
-
2005: Jakob John; Nagase Satoru; Gazdar Adi; Chien Minchen; Morozova Irina; Russo James J; Nandula Subhadra V; Murty Vundavalli V V S; Li Chi-Ming; Tycko Benjamin; Parsons Ramon
Two somatic biallelic lesions within and near SMAD4 in a human breast cancer cell line.
Genes, chromosomes & cancer 2005;42(4):372-83.
-
2005: Puc Janusz; Keniry Megan; Li Hong Shen; Pandita Tej K; Choudhury Atish D; Memeo Lorenzo; Mansukhani Mahesh; Murty Vundavalli V V S; Gaciong Zbigniew; Meek Sarah E M; Piwnica-Worms Helen; Hibshoosh Hanina; Parsons Ramon
Lack of PTEN sequesters CHK1 and initiates genetic instability.
Cancer cell 2005;7(2):193-204.
-
2004: Parsons Ramon
Human cancer, PTEN and the PI-3 kinase pathway.
Seminars in cell & developmental biology 2004;15(2):171-6.
-
2003: Sulis Maria Luisa; Parsons Ramon
PTEN: from pathology to biology.
Trends in cell biology 2003;13(9):478-83.
-
2003: Parsons Ramon; Simpson Laura
PTEN and cancer.
Methods in molecular biology (Clifton, N.J.) 2003;222():147-66.
-
2002: Wang Hong; Douglas Wayne; Lia Marie; Edelmann Winfried; Kucherlapati Raju; Podsypanina Katrina; Parsons Ramon; Ellenson Lora Hedrick
DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice.
The American journal of pathology 2002;160(4):1481-6.
-
2001: Kwabi-Addo B; Giri D; Schmidt K; Podsypanina K; Parsons R; Greenberg N; Ittmann M
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(20):11563-8.
-
2001: Podsypanina K; Lee R T; Politis C; Hennessy I; Crane A; Puc J; Neshat M; Wang H; Yang L; Gibbons J; Frost P; Dreisbach V; Blenis J; Gaciong Z; Fisher P; Sawyers C; Hedrick-Ellenson L; Parsons R
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(18):10320-5.
-
2001: Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
PTEN expression causes feedback upregulation of insulin receptor substrate 2.
Molecular and cellular biology 2001;21(12):3947-58.
-
2001: Simpson L; Parsons R
PTEN: life as a tumor suppressor.
Experimental cell research 2001;264(1):29-41.
-
2001: Li Y; Podsypanina K; Liu X; Crane A; Tan L K; Parsons R; Varmus H E
Deficiency of Pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice.
BMC molecular biology 2001;2():2.
-
2000: Rubin M A; Gerstein A; Reid K; Bostwick D G; Cheng L; Parsons R; Papadopoulos N
10q23.3 loss of heterozygosity is higher in lymph node-positive (pT2-3,N+) versus lymph node-negative (pT2-3,N0) prostate cancer.
Human pathology 2000;31(4):504-8.
-
1999: Butler M P; Wang S I; Chaganti R S; Parsons R; Dalla-Favera R
Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas.
Genes, chromosomes & cancer 1999;24(4):322-7.
-
1999: Podsypanina K; Ellenson L H; Nemes A; Gu J; Tamura M; Yamada K M; Cordon-Cardo C; Catoretti G; Fisher P E; Parsons R
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(4):1563-8.
-
1998: Li J; Simpson L; Takahashi M; Miliaresis C; Myers M P; Tonks N; Parsons R
The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
Cancer research 1998;58(24):5667-72.
-
1998: Shao X; Tandon R; Samara G; Kanki H; Yano H; Close L G; Parsons R; Sato T
Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma.
International journal of cancer. Journal international du cancer 1998;77(5):684-8.
-
1998: Bose S; Wang S I; Terry M B; Hibshoosh H; Parsons R
Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas.
Oncogene 1998;17(1):123-7.
-
1998: Cairns P; Evron E; Okami K; Halachmi N; Esteller M; Herman J G; Bose S; Wang S I; Parsons R; Sidransky D
Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers.
Oncogene 1998;16(24):3215-8.
-
1998: Wang S I; Parsons R; Ittmann M
Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):811-5.
-
1998: Parsons R
Phosphatases and tumorigenesis.
Current opinion in oncology 1998;10(1):88-91.
-
1997: Wang S I; Puc J; Li J; Bruce J N; Cairns P; Sidransky D; Parsons R
Somatic mutations of PTEN in glioblastoma multiforme.
Cancer research 1997;57(19):4183-6.
-
1997: Tashiro H; Blazes M S; Wu R; Cho K R; Bose S; Wang S I; Li J; Parsons R; Ellenson L H
Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
Cancer research 1997;57(18):3935-40.
-
1997: Arch E M; Goodman B K; Van Wesep R A; Liaw D; Clarke K; Parsons R; McKusick V A; Geraghty M T
Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease.
American journal of medical genetics 1997;71(4):489-93.
-
1997: Myers M P; Stolarov J P; Eng C; Li J; Wang S I; Wigler M H; Parsons R; Tonks N K
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(17):9052-7.
-
1997: Marsh D J; Dahia P L; Zheng Z; Liaw D; Parsons R; Gorlin R J; Eng C
Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
Nature genetics 1997;16(4):333-4.
-
1997: Liaw D; Marsh D J; Li J; Dahia P L; Wang S I; Zheng Z; Bose S; Call K M; Tsou H C; Peacocke M; Eng C; Parsons R
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Nature genetics 1997;16(1):64-7.
-
1997: Li J; Yen C; Liaw D; Podsypanina K; Bose S; Wang S I; Puc J; Miliaresis C; Rodgers L; McCombie R; Bigner S H; Giovanella B C; Ittmann M; Tycko B; Hibshoosh H; Wigler M H; Parsons R
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
Science (New York, N.Y.) 1997;275(5308):1943-7.
Sign-in to see more
